Curr Infect Dis Rep by Cope, Jennifer R. & Ali, Ibne K.
Primary Amebic Meningoencephalitis: What Have We Learned in 
the Last Five Years?
Jennifer R. Cope, MD, MPH and
Waterborne Disease Prevention Branch, Division of Foodborne, Waterborne, and Environmental 
Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Rd NE, MS C-09, Atlanta, GA 30329
Ibne K. Ali, PhD
Waterborne Disease Prevention Branch, Division of Foodborne, Waterborne, and Environmental 
Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Rd NE, MS D-66, Atlanta, GA 30329, 404-718-4157, 
iali@cdc.gov
Abstract
Primary amebic meningoencephalitis (PAM) is a devastating infection of the brain caused by the 
thermophilic free-living ameba, Naegleria fowleri. Infection can occur when water containing the 
ameba enters the body through the nose, usually during recreational water activities such as 
swimming or diving. Historically, in the United States, cases were mostly reported from the 
warmer southern-tier states. In the last five years, several notable changes have been documented 
in PAM epidemiology including a northward expansion of infections and new types of water 
exposures. The recent reports of two PAM survivors provide hope for improved outcomes with 
early diagnosis and aggressive treatment. Advanced molecular laboratory tools such as genome 
sequencing might provide more insight into the pathogenicity of Naegleria fowleri. Clinicians 
treating patients with meningitis and warm freshwater exposure are encouraged to consider PAM 
in their differential diagnoses.
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Introduction
Primary amebic meningoencephalitis (PAM) is a devastating infection of the brain caused by 
the free -living ameba, Naegleria fowleri. This ameba is commonly found in warm 
freshwater such as lakes, rivers, and hot springs and rarely infects humans. Infection can 
occur when water containing the ameba enters the body through the nose, usually during 
recreational water activities such as swimming or diving. The highly fatal and fulminant 
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nature of this infection is devastating to patient families, puts a burden on already strapped 
local and state public health departments, and can undermine the public's confidence in the 
safety of their recreational and drinking water.
Epidemiology of PAM
The first case of PAM was described by Fowler and Carter in Australia in 1965 followed by 
the first case described in the United States in 1966 [1, 2]. While PAM cases have been 
reported from several countries and Naegleria fowleri is thought to be distributed worldwide, 
the most complete data on PAM comes from the United States and therefore, this review will 
focus predominantly on PAM in the United States. From 1962 through 2015, 138 cases of 
PAM have been reported in the United States with a range of 0–8 cases annually. A review 
of cases reported in the United States through 2008 showed that PAM primarily occurs in 
previously healthy young males exposed to warm, recreational waters, predominantly in 
lakes, ponds, and reservoirs, in southern-tier states during the summer months [3]. As a 
thermophilic organism, it has been postulated that changes in the occurrence of Naegleria 
fowleri and the epidemiology of PAM might be an indicator of climate change.
Changing geography
In the last five years, several notable changes have been documented in PAM epidemiology. 
In 2010, a 7-year-old Minnesota resident died of PAM after swimming in local lakes and a 
river [4]. The patient's parents reported the child had not traveled outside of Minnesota in the 
two weeks prior to becoming ill. An environmental investigation of the lakes and river where 
the patient swam documented warm water temperatures, algal blooms, and poor water 
clarity in one lake. Water samples taken from this lake were positive for Naegleria fowleri. 
Two years later, in August 2012, a 9-year-old Minnesota resident died of PAM. This patient 
also had no travel outside of Minnesota in the two weeks prior to becoming ill and swam in 
the same lake as the patient in 2010 which had tested positive for Naegleria fowleri. These 
cases represent the northernmost documented occurrence of PAM in North America, to date, 
nearly 600 miles north of the previous northernmost reported case in Missouri. Since 2010, 
PAM cases have also been reported from other more northern U.S. states including Kansas 
and Indiana. With climate data showing consistently warming temperatures, the reports of 
PAM cases outside of the southern-tier states is cause for concern and argues that, regardless 
of geography, PAM should be considered in the differential for meningitis.
Tap water-associated cases
In addition to changes in the geography of PAM cases, there have also been changes 
documented in the route of transmission. The 2010 Yoder et al. review of PAM cases 
reported in the United States since 1962 through 2008 found that over 80% of cases were 
associated with exposure to natural waters. Tap water was an uncommon exposure (<2%) 
but had been reported to be associated with two infections from Arizona in 2002 where 
patients were exposed to untreated drinking water from a geothermal well [5]. In 2011, two 
cases of PAM were reported from Louisiana in which neither patient had recent recreational 
water exposure. However, both patients were regular users of neti pots for nasal irrigation 
[6]. Water samples taken from both of the patients’ homes were positive for Naegleria 
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fowleri including water from a kitchen bathroom sink, bathtub faucets, shower nozzle, and 
water heater; however, water samples taken from the municipal water treatment plant and 
distribution system serving the homes were negative at that time. In order to remediate the 
household plumbing and kill any remaining Naegleria fowleri, the homeowners were 
instructed to set the water heater to 160° F (71° C) and to run all taps (one faucet at a time) 
for at least 5 minutes before using the water, repeating this procedure every few weeks to 
prevent recolonization. No further cases were reported until July 2013, when a 4-year-old 
child was confirmed to have died from PAM. During the epidemiologic investigation, it was 
noted that the child had no recreational water exposure in the two weeks prior to becoming 
ill outside of playing for several hours on a backyard slip-n-slide supplied with tap water 
from the home. The home where the child played on the slip-n-slide was located in the same 
Louisiana parish as one of the 2011 PAM cases associated with neti pot use [7]. This finding 
prompted an environmental investigation of both the home plumbing system as well as the 
municipal water distribution system that served the home. Water samples were collected and 
tested for both the presence of Naegleria fowleri as well as total chlorine residual. In this 
case, Naegleria fowleri was detected in water samples from both the home plumbing system 
and the municipal water distribution system. Additionally, in the water samples where N. 
fowleri was detected, the water temperature was noted to be ≥30°C and the chlorine residual 
was below the level of detection. N. fowleri cysts and trophozoites are inactivated by free 
chlorine concentrations ≥0.5 mg/L [8, 9]; therefore, maintaining adequate levels of chlorine 
disinfectant in water distribution systems, particularly in those with elevated water 
temperatures, is thought to be an important strategy in preventing PAM cases related to tap 
water use. A similar strategy was adopted by parts of Australia in response to several PAM 
deaths in the 1960s and 1970s associated with tap water used to fill backyard pools or 
submerged heads during bathing. Since implementing increased water quality monitoring, 
ameba testing, and chlorine booster stations to maintain disinfectant residual of ≥0.5 mg/L, 
Australia has not reported any PAM deaths associated with treated tap water [10].
The use of tap water for the practice of ritual ablution that includes nasal rinsing has also 
been associated with PAM cases. Ritual nasal rinsing is included in Yogic, Ayurvedic, and 
Islamic traditions. Within the Islamic faith, ritual nasal rinsing is included in a cleansing 
process called “wudu” or “ablution” and is usually performed several times a day in 
preparation for prayer. The association of PAM with ritual ablution was first described by 
Shakoor et al. in their publication describing 13 cases of PAM in Karachi, Pakistan in 2008 
and 2009 who had no history of recreational water use but did perform ablution with tap 
water [11]. Since that time, PAM cases continue to be reported in the news from Pakistan 
and subsequent studies have demonstrated that Naegleria fowleri can be found in Karachi 
water [12]. In 2012, a PAM case was reported from St. Thomas, U.S. Virgin Islands in a 47-
year-old male whose only reported nasal freshwater exposure was tap water used for 
practicing ritual ablution [13]. He practiced ablution both in his home, where the water 
source was both untreated groundwater from a well and untreated rainwater from a cistern, 
and at a mosque, where the water source was desalinated and chlorinated municipal water. 
N. fowleri was detected in household water samples but not in the mosque water samples.
Cope and Ali Page 3














Two PAM cases reported in the United States in the last two years highlight additional issues 
when considering exposures related to the diagnosis of PAM. In 2014, PAM was confirmed 
as the cause of death in an 11-year-old Florida resident who had traveled to Costa Rica and 
participated in swimming, zip lining, and water slide use at a resort hot springs in the two 
weeks preceding his illness onset [14]. Naegleria fowleri was subsequently identified in 
water samples taken from the resort hot spring and river pond [15]. While the patient's 
parents were aware of the risk of PAM in Florida waters and took appropriate precautions, 
they did not know of the risk outside of the United States. This case highlights the 
importance of considering travel history when PAM is suspected and making the public 
aware of the risk in warm recreational waters around the world.
In June 2015, a 21-year-old California resident died of PAM after swimming in a privately-
owned pool located in a desert environment [16]. The source water for the pool was piped 
overland for approximately 1.5 miles from a mountain spring via an aging metal pipe that 
was rusted out and compromised by root systems in many places. The water temperature at 
the spring source was 50°F but had risen to 98°F where it entered the pool. Moments before 
swimming began, the participants had added an unknown amount of commercial liquid 
chlorine to the pool water in an attempt to disinfect the pool. While properly maintained 
swimming pools should not pose a risk for PAM, this case highlights how a poorly 
maintained swimming pool can harbor Naegleria fowleri. Additionally, this case 
demonstrates how water distribution systems can become ideal environments for the growth 
of Naegleria fowleri.
Clinical presentation and treatment
The diagnosis of PAM carries a high mortality rate of greater than 97%. The clinical 
presentation of PAM is often indistinguishable from bacterial meningitis with headache, 
fever, nausea, and vomiting being the most common presenting signs and symptoms [17]. 
By the time other more common causes of meningitis are ruled out and the diagnosis of 
PAM is considered, it is often too late to save the patient from the cerebral edema that 
quickly develops and causes death. U.S. data show a median incubation period of 5 days and 
a median time from onset of symptoms to death of five days [17]. Most patients presented to 
medical care with signs or symptoms indicative of central nervous system involvement. 
Analysis of cerebrospinal fluid (CSF) usually reveals a high opening pressure, a 
predominantly neutrophilic pleocytosis, elevated protein concentration, and low glucose 
levels. Only 27% of U.S. cases were diagnosed before death [17]. These findings indicate 
the diagnosis is often considered too late or not at all in patients with meningitis.
Prior to 2013, there had been only three well-documented survivors worldwide, including 
one from the United States in 1978. These three early survivors were all treated with 
conventional (non-deoxycholate formulation) amphotericin B (intravenous and intrathecal) 
alone or in combination with rifampin, an azole drug (miconazole or fluconazole), and 
adjunctive therapy with steroids to control cerebral edema [18-20]. While this combination 
of drugs continued to be used as first-line therapy in patients diagnosed with PAM prior to 
death, no additional survivors were reported until July 2013, when a 12-year-old female 
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from Arkansas was diagnosed with PAM within 48 hours of symptom onset. Her treatment 
included intravenous and intrathecal conventional amphotericin B, azithromycin, 
fluconazole, rifampin, and miltefosine, which, at that time, was an investigational drug 
available through the Centers for Disease Control and Prevention (CDC). She was also 
treated aggressively for cerebral edema and the resulting elevated intracranial pressure with 
dexamethasone, CSF drainage via an external ventricular drain, hyperosmolar therapy with 
mannitol and 3% saline, moderate hyperventiliation, and induced hypothermia (32–34°C)
[21]. After 55 days in the hospital, this patient made a full recovery, returning to school with 
no residual deficits. During the same summer, another PAM patient, an 8-year-old male in 
Texas, also survived, although with significant neurologic deficits [22]. He received the 
same treatment (except for induced hypothermia) as the 12-year-old Arkansas survivor, but 
was not diagnosed and treated until approximately five days after his symptoms began.
Given changes in the geography of PAM, new modes of transmission via tap water, and the 
possibility of survival if treatment is initiated early and aggressively, clinicians in all regions 
of the United States treating patients with meningitis should consider the diagnosis of PAM 
and inquire about water exposure in the two weeks prior to symptom onset. A presumptive 
diagnosis can be attempted by examining a wet mount of CSF to look for motile amebae. 
Regardless of CSF findings, clinicians are encouraged to consult with experts at CDC 24/7 if 
the diagnosis of PAM is being considered by calling the CDC Emergency Operations Center 
at 770-488-7100. CDC can assist with treatment recommendations including facilitating the 
use of miltefosine and arranging for shipment of specimens for diagnostic testing. If motile 
amebae are seen in the CSF, laboratory staff are encouraged to obtain high-resolution images 
for examination by CDC experts. Sending images to CDC can facilitate a preliminary 
diagnosis while specimens are sent to CDC for confirmatory testing.
Diagnostic testing
Clinical specimens
For PAM, CSF and brain biopsy tissue remain the most useful specimen types for diagnosis 
[23, 24]. These specimens should be collected aseptically, and kept at room temperature 
(~25°C) prior to any laboratory examinations. These conditions favor survival of the 
thermophilic amebae in the specimens, facilitating direct observation of live amebae upon 
microscopic examination, and enabling growth in appropriate culture media. Personnel 
handling these specimens should wear appropriate protective equipment such as gloves and 
surgical masks, and should open the containers containing the specimens only inside a 
biological safety cabinet to minimize risk of unintentional infection. For molecular 
diagnosis, both CSF and brain biopsy tissue are useful. However, fresh or frozen brain tissue 
is preferred over formalin-fixed tissue as the formalin treatment adversely affects the DNA 
quality. Formalin-fixed tissue is useful for the detection of amebae by immunohistochemical 
assays.
Microscopic identification of amebae in CSF
In suspected PAM patients, a wet mount of CSF should be examined under a microscope 
immediately after collection for the presence of motile trophozoites. If an immediate 
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microscopic examination is not possible, then the CSF may be stored at room temperature 
(~25°C) until it is viewed under the microscope. A gentle agitation of the container holding 
the CSF may be helpful to dislodge any amebae that are adhered to the container before 
observation under the microscope. Also, brief centrifugation of the CSF specimen at 5,000 × 
g for 5 minutes may be helpful to concentrate amebae at the bottom of the container prior to 
placing a small volume on a microscopic slide. Following centrifugation, the supernatant 
should be carefully removed, leaving about 200—300 μL of residual liquid without 
dislodging any visible pellet. The microscopic slide containing the CSF may be placed 
inside a 35-37°C incubator to warm it, which facilitates the movement of any N. fowleri 
amebae. Smears of CSF should be stained with Giemsa or Wright stains to identify the 
trophozoite of N. fowleri. The ameba can be clearly differentiated from host cells by the 
nucleus with its centrally placed large nucleolus. Gram staining of CSF is generally not 
useful. The three main advantages of microscopic identification of N. fowleri in CSF or 
brain tissue are its simplicity, rapidity, and low cost. However, the major disadvantage is that 
an expert microscopist or pathologist is needed to properly identify an ameba from other 
things such as host cells. This method is also dependent on the morphological integrity of 
the ameba on the test specimens.
Molecular detection
Recently, molecular techniques based on polymerase chain reaction (PCR) and isothermal 
DNA amplification have been developed for the specific identification of N. fowleri in 
clinical and environmental samples [25-33]. Both multicopy mitochondrial 5.8S and 18S 
rRNA genes and internal transcribed spacers (ITS), as well as single copy genomic DNA 
have been used to develop these PCR assays. Streby et al. compared four real-time PCR 
assays in their ability to detect N. fowleri and other Naegleria spp. in environmental 
samples. They concluded that methods developed by Qvarnstrom et al. (utilizing 18S rRNA 
gene) and Mull et al. (utilizing 5.8S rRNA gene and ITS region) performed equally well and 
showed similar sensitivities and specificities. The TaqMan real-time PCR assay by 
Qvarnstrom et al. has also been widely used to test clinical specimens such as CSF or brain 
tissue collected from PAM patients, especially in the United States. For CSF and fresh or 
frozen brain tissue samples, it takes about 2–3 hours to identify N. fowleri from the time the 
specimen is received in the laboratory. This TaqMan real-time PCR can detect a single 
ameba in a patient sample because there are hundreds of copies of target DNA per ameba. 
This method is also highly specific for N. fowleri and it does not amplify DNA from two 
other pathogenic free-living amebae, Acanthamoeba castellanii or Balamuthia mandrillaris 
that have been implicated in human infections. Mahittikorn et al. developed a novel loop-
mediated isothermal amplification (LAMP) assay for the detection of N. fowleri. LAMP 
assays do not need sophisticated PCR instrument, and the amplification products can be 
visualized by the naked eye. The N. fowleri LAMP assay was applied to both environmental 
water samples and ameba-spiked CSFs, appeared to be specific for N. fowleri, and could 
detect a single ameba per reaction [27].
PCR is now considered the gold standard for diagnosis and is the first diagnostic test that is 
performed at CDC on specimens from a suspected PAM case. With proper notification of 
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specimen shipment, the CDC Free-Living and Intestinal Amebas (FLIA) Laboratory can 
provide same-day PCR results for clinical decision-making.
Antigen detection
Mouse monoclonal antibodies (mAbs) have been developed against N. fowleri. In 1987, 
Visvesvara and colleagues [34] first developed the mAbs against N. fowleri and used these 
to detect N. fowleri amebae in brain sections of PAM patients. In the indirect 
immunofluorescence (IIF) assay, these mAbs reacted intensely with all strains of N. fowleri 
originating from different geographic areas, but showed no reactivity with four other species 
of Naegleria (N. gruberi, N. jadini, N. lovaniensis, and N. australiensis) that were never 
documented to cause disease in humans. These mAbs also did not show any reactivity 
towards a strain of Acanthamoeba castellanii. N. fowleri amebae concentrated directly from 
contaminated water can be identified quickly by this IIF assay, suggesting good sensitivity 
of the test. The advantage of the IIF assay is its ability to mark the amebae with fluorescence 
so that the microscopist can more easily distinguish amebae from other forms. The CDC 
FLIA Laboratory usually reserves antigen detection IIF assay for use on formalin-preserved 
autopsy specimens for the diagnosis of PAM.
Several enzyme-linked immunosorbent assays (ELISAs) have been developed based on 
monoclonal and polyclonal antibodies for the detection of Naegleria fowleri. However, they 
have not been tested in clinical specimens for the diagnosis of PAM. Advantages of using 
antigen detection ELISA assay over microscopic detection include the ability to detect 
amebic antigens in the absence of intact amebae, rapid turnaround, and ability to be used by 
laboratory staff otherwise not trained in ameba morphology. One caveat of ELISA is its poor 
sensitivity compared to PCR assays.
Serologic tests
Seidel [19] reported a specific antibody response to N. fowleri in the 1978 California PAM 
survivor with a titer of 1:4096 demonstrated by immunofluorescence-based antibody (IFA) 
assay in the serum samples collected as early as 7 days after admission to hospital. The high 
antibody titers persisted >4 years in this survivor. However, serologic tests are generally not 
suitable for PAM diagnosis for several reasons: (1) disease progression in PAM cases is so 
rapid that they may not mount an antibody response, (2) even if there is an antibody 
response (assuming specificity against N. fowleri), serology will not be able to distinguish 
between an acute infection and a past exposure, and (3) the test is time consuming and not 
useful for making a rapid diagnosis.
Advanced molecular techniques
Genome sequencing
Genome sequencing of free-living amebae is still in its infancy. Accurately annotated 
genome sequences may provide crucial information about the pathogenicity and virulence of 
an organism. Sometimes, a genomic comparison between a pathogenic species and a closely 
related non-pathogenic species can help identify pathogenicity or virulence factors. The 
genome of a non-pathogenic Naegleria species, N. gruberi, was sequenced in 2010 and the 
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genome sequence of N. fowleri was reported in 2014 [35, 36]. However, comparison of the 
two suggest that the N. gruberi genome is too diverse to compare to N. fowleri to identify 
pathogenicity or virulence factors in the latter ameba. It has been suggested that N. 
lovaniensis, another non-pathogenic species of Naegleria, is possibly the closest to N. 
fowleri based on the small subunit (SSU) rDNA and 5.8S rDNA sequences (the difference 
are only 0.8% and 0.6%, respectively) [37]. However, the genome sequence of N. 
lovaniensis has not yet been reported. Once optimized, genome comparison of N. fowleri 
strains isolated from PAM patients and those from the environmental sources should provide 
important information in identifying pathogenicity and virulence factors in this species. 
Current genotyping tools classify all N. fowleri strains from the United States into three 
categories [38] and are not useful for linking cases with sources of exposure. Next 
generation sequencing of environmental and clinical strains may help identify regions that 
would allow the development of more discriminatory genotyping tools for infection source-
tracking in clinical PAM cases and to conduct molecular epidemiology surveys.
Transcriptomic (RNA sequencing) and proteomic analyses
Comparative studies using transcriptomic and proteomic data from highly and weakly 
virulent N. fowleri trophozoites have identified about two dozen potential targets that may 
be directly involved in amebic pathogenicity and virulence [36]. Recently, a matrix-assisted 
laser-desorption-ionization-time-of-flight (MALDITOF) mass spectrometry approach has 
been used to identify protein biomarkers for pathogenic N. fowleri using 18 N. fowleri 
strains (including 14 from PAM cases and 4 from environmental sources) and 6 non-
pathogenic Naegleria species: N. gruberi, N. lovaniensis, N. australiensis, N. dunnebackei, 
N. jadinii, and N. italica [39]. This study identified several biomarkers that can differentiate 
N. fowleri from other species within the genus Naegleria, as well as some common 
biomarkers for all N. fowleri isolates. Some of the N. fowleri-specific biomarkers (proteins) 
deserve further characterization in relation to their roles in amebic pathogenicity and 
virulence.
Conclusions
The last five years have shown that PAM remains a devastating central nervous system 
infection associated with warm freshwater exposure. Though most clinicians may never 
encounter a case, the almost always fatal outcome and possibility for survival if treated early 
and aggressively argue that this infection should be considered in the differential diagnosis 
of meningitis, particularly in the warm summer months in patients with recent freshwater 
exposure. Because of the changing geography and types of water exposures, clinicians in all 
regions should also consider PAM as the cause for meningitis. Diagnostic assistance and 
treatment recommendations are available 24/7 through consultation with CDC. New insights 
into this pathogen will be gained through the use of advanced molecular methods.
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A cytospin of fixed CSF showing a N. fowleri trophozoite (arrow) stained with Giemsa-
Wright amidst polymorphonuclear leukocytes and a few lymphocytes. Within the 
trophozoite, the nucleus and nucleolus can be seen. Magnification ×1000 [image is from 
CDC and can found at http://www.cdc.gov/parasites/naegleria/naegleria-fowleri-
images.html]
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